{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:29:31Z","timestamp":1793410171019,"version":"4.5.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s13555-025-01433-y","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T10:55:08Z","timestamp":1747565708000},"page":"1953-1971","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Practical Approach to Chronic Hand Eczema"],"prefix":"10.1007","volume":"15","author":[{"given":"Sophia A.","family":"Mense","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawyeh","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6510-399X","authenticated-orcid":false,"given":"Raj","family":"Chovatiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,18]]},"reference":[{"issue":"4","key":"1433_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1600-0536.1999.tb06131.x","volume":"41","author":"L Vestergaard","year":"1999","unstructured":"Vestergaard L, Clemmensen OJ, S\u00f8rensen FB, Andersen KE. Histological distinction between early allergic and irritant patch test reactions: follicular spongiosis may be characteristic of early allergic contact dermatitis. Contact Dermatitis. 1999;41(4):207\u201310. https:\/\/doi.org\/10.1111\/j.1600-0536.1999.tb06131.x.","journal-title":"Contact Dermatitis"},{"issue":"1","key":"1433_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/DAD.0000000000000842","volume":"40","author":"VG Frings","year":"2018","unstructured":"Frings VG, B\u00f6er-Auer A, Breuer K. Histomorphology and immunophenotype of eczematous skin lesions revisited\u2014skin biopsies are not reliable in differentiating allergic contact dermatitis, irritant contact dermatitis, and atopic dermatitis. Am J Dermatopathol. 2018;40(1):7. https:\/\/doi.org\/10.1097\/DAD.0000000000000842.","journal-title":"Am J Dermatopathol"},{"issue":"12","key":"1433_CR3","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1111\/jdv.13308","volume":"29","author":"T Agner","year":"2015","unstructured":"Agner T, Aalto-Korte K, Andersen KE, et al. Classification of hand eczema. J Eur Acad Dermatol Venereol JEADV. 2015;29(12):2417\u201322. https:\/\/doi.org\/10.1111\/jdv.13308.","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"10","key":"1433_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00105-019-04474-5","volume":"70","author":"S Molin","year":"2019","unstructured":"Molin S. Pathogenesis of hand eczema. Hautarzt Z Dermatol Venerol Verwandte Geb. 2019;70(10):755\u20139. https:\/\/doi.org\/10.1007\/s00105-019-04474-5.","journal-title":"Hautarzt Z Dermatol Venerol Verwandte Geb"},{"issue":"10470","key":"1433_CR5","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/S0140-6736(24)01810-5","volume":"404","author":"S Weidinger","year":"2024","unstructured":"Weidinger S, Novak N. Hand eczema. Lancet Lond Engl. 2024;404(10470):2476\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(24)01810-5.","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"1433_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/bjd.20142","volume":"185","author":"A Schnuch","year":"2021","unstructured":"Schnuch A. Hand eczema in young people: atopic dermatitis and beyond. Br J Dermatol. 2021;185(1):17\u20138. https:\/\/doi.org\/10.1111\/bjd.20142.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1433_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/cod.13804","volume":"84","author":"AS Quaade","year":"2021","unstructured":"Quaade AS, Simonsen AB, Halling AS, Thyssen JP, Johansen JD. Prevalence, incidence, and severity of hand eczema in the general population\u2014a systematic review and meta-analysis. Contact Dermatitis. 2021;84(6):361\u201374. https:\/\/doi.org\/10.1111\/cod.13804.","journal-title":"Contact Dermatitis"},{"issue":"3","key":"1433_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/cod.14020","volume":"86","author":"MM Sloot","year":"2022","unstructured":"Sloot MM, Loman L, Romeijn GLE, Rosenberg FM, Arents BWM, Schuttelaar MLA. Patients\u2019 perspectives on quality of care for chronic hand eczema: a qualitative study. Contact Dermatitis. 2022;86(3):204\u201312. https:\/\/doi.org\/10.1111\/cod.14020.","journal-title":"Contact Dermatitis"},{"issue":"3","key":"1433_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/0019-5154.131372","volume":"59","author":"US Agarwal","year":"2014","unstructured":"Agarwal US, Besarwal RK, Gupta R, Agarwal P, Napalia S. Hand eczema. Indian J Dermatol. 2014;59(3):213\u201324. https:\/\/doi.org\/10.4103\/0019-5154.131372.","journal-title":"Indian J Dermatol"},{"key":"1433_CR10","doi-asserted-by":"publisher","unstructured":"Russo JP, Alfonso JH, Nardelli A. Work-related and occupational hand eczema (OHE), diagnosis and treatment. In: Gim\u00e9nez-Arnau AM, Maibach HI, editors. Handbook of occupational dermatoses. Springer International Publishing; 2023. p. 115\u2013125. https:\/\/doi.org\/10.1007\/978-3-031-22727-1_10.","DOI":"10.1007\/978-3-031-22727-1_10"},{"issue":"1","key":"1433_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1600-0536.2008.01362.x","volume":"59","author":"T Agner","year":"2008","unstructured":"Agner T, Andersen KE, Brandao FM, et al. Hand eczema severity and quality of life: a cross-sectional, multicentre study of hand eczema patients. Contact Dermatitis. 2008;59(1):43\u20137. https:\/\/doi.org\/10.1111\/j.1600-0536.2008.01362.x.","journal-title":"Contact Dermatitis"},{"issue":"6","key":"1433_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/cod.12366","volume":"72","author":"A Kouris","year":"2015","unstructured":"Kouris A, Armyra K, Christodoulou C, et al. Quality of life, anxiety, depression and obsessive-compulsive tendencies in patients with chronic hand eczema. Contact Dermatitis. 2015;72(6):367\u201370. https:\/\/doi.org\/10.1111\/cod.12366.","journal-title":"Contact Dermatitis"},{"issue":"3","key":"1433_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12016-016-8548-5","volume":"51","author":"PY Ong","year":"2016","unstructured":"Ong PY, Leung DYM. Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;51(3):329\u201337. https:\/\/doi.org\/10.1007\/s12016-016-8548-5.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1433_CR14","unstructured":"Nemeth V, Syed HA, Evans J. Eczema. In: StatPearls. StatPearls Publishing; 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538209\/. Accessed 21 Jan 2025."},{"issue":"4","key":"1433_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2340\/00015555-1539","volume":"93","author":"JP Thyssen","year":"2013","unstructured":"Thyssen JP, Johansen JD, Zachariae C, Menn\u00e9 T, Linneberg A. Xerosis is associated with atopic dermatitis, hand eczema and contact sensitization independent of filaggrin gene mutations. Acta Derm Venereol. 2013;93(4):406\u201310. https:\/\/doi.org\/10.2340\/00015555-1539.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"1433_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/jdv.17814","volume":"36","author":"J Wang","year":"2022","unstructured":"Wang J, Tischer C, Standl M, et al. Lifetime prevalence and determinants of hand eczema in an adolescent population in Germany: 15-year follow-up of the LISA cohort study. J Eur Acad Dermatol Venereol. 2022;36(4):547\u201356. https:\/\/doi.org\/10.1111\/jdv.17814.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1433_CR17","doi-asserted-by":"crossref","unstructured":"Association between atopic dermatitis and hand eczema: a systematic review and meta\u2010analysis. Br J Dermatol. Oxford Academic. https:\/\/academic.oup.com\/bjd\/article-abstract\/178\/4\/879\/6602459?redirectedFrom=fulltext&login=true. Accessed 2 Feb 2025.","DOI":"10.1111\/bjd.16147"},{"issue":"5","key":"1433_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/cosmetics10050134","volume":"10","author":"I Japund\u017ei\u0107","year":"2023","unstructured":"Japund\u017ei\u0107 I, Bembi\u0107 M, \u0160piljak B, Para\u0107 E, Macan J, Lugovi\u0107-Mihi\u0107 L. Work-related hand eczema in healthcare workers: etiopathogenic factors, clinical features, and skin care. Cosmetics. 2023;10(5):134. https:\/\/doi.org\/10.3390\/cosmetics10050134.","journal-title":"Cosmetics"},{"issue":"4","key":"1433_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/cod.14379","volume":"89","author":"FB Sedeh","year":"2023","unstructured":"Sedeh FB, Michaelsd\u00f3ttir TE, Christiensen KB, Mortensen OS, Jemec GBE, Ibler KS. Prevalence and risk factors for hand eczema among professional hospital cleaners in Denmark: a cross-sectional questionnaire-based study. Contact Dermatitis. 2023;89(4):241\u20139. https:\/\/doi.org\/10.1111\/cod.14379.","journal-title":"Contact Dermatitis"},{"key":"1433_CR20","doi-asserted-by":"publisher","first-page":"adv00681","DOI":"10.2340\/actadv.v102.360","volume":"102","author":"W Jamil","year":"2022","unstructured":"Jamil W, Svensson \u00c5, Josefson A, Lindberg M, von Kobyletzki L. Incidence rate of hand eczema in different occupations: a systematic review and meta-analysis. Acta Derm Venereol. 2022;102:adv00681. https:\/\/doi.org\/10.2340\/actadv.v102.360.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"1433_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40257-021-00669-6","volume":"23","author":"A Armstrong","year":"2022","unstructured":"Armstrong A, Hahn-Pedersen J, Bartlett C, Glanville J, Thyssen JP. Economic burden of chronic hand eczema: a review. Am J Clin Dermatol. 2022;23(3):287\u2013300. https:\/\/doi.org\/10.1007\/s40257-021-00669-6.","journal-title":"Am J Clin Dermatol"},{"issue":"17","key":"1433_CR22","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.3390\/jcm12175741","volume":"12","author":"A Zalewski","year":"2023","unstructured":"Zalewski A, Krajewski PK, Szepietowski JC. Psychosocial consequences of hand eczema\u2014a prospective cross-sectional study. J Clin Med. 2023;12(17):5741. https:\/\/doi.org\/10.3390\/jcm12175741.","journal-title":"J Clin Med"},{"issue":"19","key":"1433_CR23","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1056\/NEJMcp1104084","volume":"367","author":"PJ Coenraads","year":"2012","unstructured":"Coenraads PJ. Hand eczema. N Engl J Med. 2012;367(19):1829\u201337. https:\/\/doi.org\/10.1056\/NEJMcp1104084.","journal-title":"N Engl J Med"},{"issue":"11","key":"1433_CR24","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.3390\/biomedicines10112927","volume":"10","author":"F Lobefaro","year":"2022","unstructured":"Lobefaro F, Gualdi G, Di Nuzzo S, Amerio P. Atopic dermatitis: clinical aspects and unmet needs. Biomedicines. 2022;10(11):2927. https:\/\/doi.org\/10.3390\/biomedicines10112927.","journal-title":"Biomedicines"},{"key":"1433_CR25","unstructured":"Logan Kolb, Ferrer-Bruker SJ. Atopic dermatitis. In: StatPearls. StatPearls Publishing; 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448071\/. Accessed 21 Jan 2025."},{"issue":"4","key":"1433_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11882-023-01070-5","volume":"23","author":"TK Karagounis","year":"2023","unstructured":"Karagounis TK, Cohen DE. Occupational hand dermatitis. Curr Allergy Asthma Rep. 2023;23(4):201\u201312. https:\/\/doi.org\/10.1007\/s11882-023-01070-5.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"1433_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1600-0536.2008.01317.x","volume":"58","author":"CM de Jongh","year":"2008","unstructured":"de Jongh CM, John SM, Bruynzeel DP, et al. Cytokine gene polymorphisms and susceptibility to chronic irritant contact dermatitis. Contact Dermatitis. 2008;58(5):269\u201377. https:\/\/doi.org\/10.1111\/j.1600-0536.2008.01317.x.","journal-title":"Contact Dermatitis"},{"issue":"2","key":"1433_CR28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jaci.2012.06.048","volume":"131","author":"JK Gittler","year":"2013","unstructured":"Gittler JK, Krueger JG, Guttman-Yassky E. Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis. J Allergy Clin Immunol. 2013;131(2):300\u201313. https:\/\/doi.org\/10.1016\/j.jaci.2012.06.048.","journal-title":"J Allergy Clin Immunol"},{"key":"1433_CR29","doi-asserted-by":"crossref","unstructured":"Leonard A, Guttman-Yassky E. The unique molecular signatures of contact dermatitis and implications for treatment. Clin Rev Allergy Amp Immunol. 2019;56(1):1\u20139. https:\/\/go.gale.com\/ps\/i.do?p=AONE&sw=w&issn=10800549&v=2.1&it=r&id=GALE%7CA570250161&sid=googleScholar&linkaccess=abs. Accessed 4 Feb 2025.","DOI":"10.1007\/s12016-018-8685-0"},{"issue":"2","key":"1433_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s13671-021-00351-4","volume":"11","author":"K Patel","year":"2022","unstructured":"Patel K, Nixon R. Irritant contact dermatitis\u2014a review. Curr Dermatol Rep. 2022;11(2):41\u201351. https:\/\/doi.org\/10.1007\/s13671-021-00351-4.","journal-title":"Curr Dermatol Rep"},{"issue":"3","key":"1433_CR31","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1365-2133.2008.08730.x","volume":"159","author":"CM De Jongh","year":"2008","unstructured":"De Jongh CM, Khrenova L, Verberk MM, et al. Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: a case\u2013control study. Br J Dermatol. 2008;159(3):621\u20137. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08730.x.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1433_CR32","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/bjd.12035","volume":"167","author":"L Landeck","year":"2012","unstructured":"Landeck L, Visser M, Skudlik C, Brans R, Kezic S, John SM. Clinical course of occupational irritant contact dermatitis of the hands in relation to filaggrin genotype status and atopy. Br J Dermatol. 2012;167(6):1302\u20139. https:\/\/doi.org\/10.1111\/bjd.12035.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1433_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s13671-022-00379-0","volume":"11","author":"AM Gim\u00e9nez-Arnau","year":"2022","unstructured":"Gim\u00e9nez-Arnau AM, Pesqu\u00e9 D, Maibach HI. Contact urticaria syndrome: a comprehensive review. Curr Dermatol Rep. 2022;11(4):194\u2013201. https:\/\/doi.org\/10.1007\/s13671-022-00379-0.","journal-title":"Curr Dermatol Rep"},{"key":"1433_CR34","unstructured":"Vethachalam S, Persaud Y. Contact urticaria. In: StatPearls. StatPearls Publishing; 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK549890\/. Accessed 4 Feb 2025."},{"key":"1433_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.4103\/0378-6323.100547","volume":"78","author":"C Lakshmi","year":"2012","unstructured":"Lakshmi C, Srinivas CR. Hand eczema: an update. Indian J Dermatol Venereol Leprol. 2012;78:569. https:\/\/doi.org\/10.4103\/0378-6323.100547.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"1433_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12840","volume":"32","author":"GR Lee","year":"2019","unstructured":"Lee GR, Maarouf M, Hendricks AK, Lee DE, Shi VY. Current and emerging therapies for hand eczema. Dermatol Ther. 2019;32(3): e12840.","journal-title":"Dermatol Ther"},{"issue":"3","key":"1433_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1600-0536.2011.02022.x","volume":"66","author":"D Patel","year":"2012","unstructured":"Patel D, Belsito DV. The detection of clinically relevant contact allergens with a standard screening tray of 28 allergens. Contact Dermatitis. 2012;66(3):154\u20138. https:\/\/doi.org\/10.1111\/j.1600-0536.2011.02022.x.","journal-title":"Contact Dermatitis"},{"key":"1433_CR38","unstructured":"Murphy PB, Atwater AR, Mueller M. Allergic contact dermatitis. In: StatPearls. StatPearls Publishing; 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532866\/. Accessed 5 Feb 2025."},{"issue":"5","key":"1433_CR39","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00018-011-0846-8","volume":"69","author":"M Peiser","year":"2011","unstructured":"Peiser M, Tralau T, Heidler J, et al. Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Cell Mol Life Sci CMLS. 2011;69(5):763\u201381. https:\/\/doi.org\/10.1007\/s00018-011-0846-8.","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"6","key":"1433_CR40","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.jaad.2022.08.041","volume":"87","author":"MF Qian","year":"2022","unstructured":"Qian MF, Li S, Honari G, Sarin KY, Chen JK. Sociodemographic disparities in patch testing for commercially insured patients with dermatitis: a retrospective analysis of administrative claims data. J Am Acad Dermatol. 2022;87(6):1411\u20133. https:\/\/doi.org\/10.1016\/j.jaad.2022.08.041.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1433_CR41","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/bjd.21680","volume":"187","author":"CM Woodruff","year":"2022","unstructured":"Woodruff CM, Kaur G, Botto N. Racial disparities in access to patch testing: a cross-sectional study. Br J Dermatol. 2022;187(5):784\u20135. https:\/\/doi.org\/10.1111\/bjd.21680.","journal-title":"Br J Dermatol"},{"issue":"7","key":"1433_CR42","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/jdv.19055","volume":"37","author":"H R\u00f6nsch","year":"2023","unstructured":"R\u00f6nsch H, Schiffers F, Ofenloch R, et al. Chronic hand eczema in Europe: patient experiences and perspectives (CHEPEP) in qualitative interviews. J Eur Acad Dermatol Venereol JEADV. 2023;37(7):1396\u2013405. https:\/\/doi.org\/10.1111\/jdv.19055.","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"9","key":"1433_CR43","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/ddg.15179","volume":"21","author":"A Bauer","year":"2023","unstructured":"Bauer A, Brans R, Brehler R, et al. S2k guideline diagnosis, prevention, and therapy of hand eczema. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2023;21(9):1054\u201374. https:\/\/doi.org\/10.1111\/ddg.15179.","journal-title":"J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG"},{"key":"1433_CR44","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/j.1365-2133.2009.09402.x","volume":"161","author":"M Hald","year":"2009","unstructured":"Hald M, Agner T, Blands J, Johansen JD. Delay in medical attention to hand eczema: a follow-up study. Br J Dermatol. 2009;161:1294\u2013300. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09402.x.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1433_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/cod.12432","volume":"73","author":"JD Johansen","year":"2015","unstructured":"Johansen JD, Aalto-Korte K, Agner T, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing\u2014recommendations on best practice. Contact Dermatitis. 2015;73(4):195\u2013221. https:\/\/doi.org\/10.1111\/cod.12432.","journal-title":"Contact Dermatitis"},{"key":"1433_CR46","doi-asserted-by":"publisher","unstructured":"John SM, Bonertz A, Zimmer J, et al. Severely compromised supply of patch test allergens in Europe hampers adequate diagnosis of occupational and non-occupational contact allergy. A European Society of Contact Dermatitis (ESCD), European Academy of Allergy and Clinical Immunology (EAACI), European Academy of Dermatology and Venereology (EADV) task forces \u201cContact Dermatitis\u201d and \u201cOccupational Skin Disease\u201d position paper. Contact Dermatitis. 2024;91(2):91\u2013103. https:\/\/doi.org\/10.1111\/cod.14580.","DOI":"10.1111\/cod.14580"},{"key":"1433_CR47","doi-asserted-by":"publisher","unstructured":"(PDF) Patch testing for contact allergy and allergic contact dermatitis. ResearchGate. 2024. https:\/\/doi.org\/10.2174\/1874838400801010042.","DOI":"10.2174\/1874838400801010042"},{"issue":"5","key":"1433_CR48","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jaip.2015.05.001","volume":"3","author":"L Fonacier","year":"2015","unstructured":"Fonacier L. A practical guide to patch testing. J Allergy Clin Immunol Pract. 2015;3(5):669\u201375. https:\/\/doi.org\/10.1016\/j.jaip.2015.05.001.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"1433_CR49","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.0105-1873.2004.00351.x","volume":"50","author":"SI Ale","year":"2004","unstructured":"Ale SI, Maibach HI. Reproducibility of patch test results: a concurrent right-versus-left study using TRUE Test\u2122. Contact Dermatitis. 2004;50(5):304\u201312. https:\/\/doi.org\/10.1111\/j.0105-1873.2004.00351.x.","journal-title":"Contact Dermatitis"},{"key":"1433_CR50","unstructured":"Douglas JD. A review of allergic contact dermatitis & patch testing. J Dermatol Physician Assist. 2010;4(4):15. https:\/\/journals.lww.com\/jdpa\/citation\/2010\/04040\/a_review_of_allergic_contact_dermatitis___patch.7.aspx. Accessed 27 Mar 2025."},{"issue":"3","key":"1433_CR51","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4103\/ijd.ijd_965_21","volume":"67","author":"A Bilgic","year":"2022","unstructured":"Bilgic A, Bozca BC, Subas\u0131 GY, et al. Standard patch test results and clinical relevance: a cross-sectional study of 10-year retrospective experience. Indian J Dermatol. 2022;67(3):258\u201364. https:\/\/doi.org\/10.4103\/ijd.ijd_965_21.","journal-title":"Indian J Dermatol"},{"issue":"S4","key":"1433_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/jdv.14319","volume":"31","author":"JH Alfonso","year":"2017","unstructured":"Alfonso JH, Bauer A, Bensefa-Colas L, et al. Minimum standards on prevention, diagnosis and treatment of occupational and work-related skin diseases in Europe\u2014position paper of the COST Action StanDerm (TD 1206). J Eur Acad Dermatol Venereol. 2017;31(S4):31\u201343. https:\/\/doi.org\/10.1111\/jdv.14319.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"1433_CR53","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/j.1365-2133.2009.09139.x","volume":"160","author":"M Hald","year":"2009","unstructured":"Hald M, Agner T, Blands J, et al. Clinical severity and prognosis of hand eczema. Br J Dermatol. 2009;160(6):1229\u201336. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09139.x.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1433_CR54","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/s0190-9622(03)02112-1","volume":"49","author":"DL Kadyk","year":"2003","unstructured":"Kadyk DL, McCarter K, Achen F, Belsito DV. Quality of life in patients with allergic contact\ndermatitis. J Am Acad Dermatol. 2003;49(6):1037-1048.\nhttps:\/\/doi.org\/10.1016\/s0190-9622(03)02112-1.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1433_CR55","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/DER.0000000000000598","volume":"31","author":"S Capucci","year":"2020","unstructured":"Capucci S, Hahn-Pedersen J, Vilsb\u00f8ll A, Kragh N. Impact of atopic dermatitis and chronic hand eczema on quality of life compared with other chronic diseases. Dermatitis. 2020;31(3):178\u201384. https:\/\/doi.org\/10.1097\/DER.0000000000000598.","journal-title":"Dermatitis"},{"key":"1433_CR56","doi-asserted-by":"publisher","DOI":"10.1089\/derm.2024.0365","author":"M Bruze","year":"2025","unstructured":"Bruze M, Svedman C. Clarification and Modification of the International Contact Dermatitis Research Group Classification of Patch Test Reactions on Behalf of the International Contact Dermatitis Research Group. Dermat Contact Atopic Occup Drug. 2025. https:\/\/doi.org\/10.1089\/derm.2024.0365.","journal-title":"Dermat Contact Atopic Occup Drug."},{"issue":"6","key":"1433_CR57","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/cod.14407","volume":"89","author":"AS Quaade","year":"2023","unstructured":"Quaade AS, Alinaghi F, Dietz JBN, Erichsen CY, Johansen JD. Chronic hand eczema: a prevalent disease in the general population associated with reduced quality of life and poor overall health measures. Contact Dermatitis. 2023;89(6):453\u201363. https:\/\/doi.org\/10.1111\/cod.14407.","journal-title":"Contact Dermatitis"},{"key":"1433_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.09.048","author":"R Bissonnette","year":"2024","unstructured":"Bissonnette R, Agner T, Molin S, Guttman-Yassky E. Hand eczema. Part 1: epidemiology, pathogenesis, diagnosis and work-up. J Am Acad Dermatol. 2024. https:\/\/doi.org\/10.1016\/j.jaad.2024.09.048.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1433_CR59","doi-asserted-by":"publisher","first-page":"111","DOI":"10.25259\/IJSA_16_2024","volume":"3","author":"B Panambur","year":"2024","unstructured":"Panambur B. Patch testing with Indian standard series of 20 allergens in 125 patients of chronic dermatitis and dermatoses. Indian J Skin Allergy. 2024;3(2):111\u20138. https:\/\/doi.org\/10.25259\/IJSA_16_2024.","journal-title":"Indian J Skin Allergy"},{"issue":"3","key":"1433_CR60","doi-asserted-by":"publisher","first-page":"78","DOI":"10.15586\/aei.v52i3.1024","volume":"52","author":"JR Rigolon","year":"2024","unstructured":"Rigolon JR, Barbosa SS, Goudouris ES. Patch test in Brazilian children with a clinical diagnosis of atopic dermatitis: a cross-sectional study using an extended patch test battery. Allergol Immunopathol (Madr). 2024;52(3):78\u201386. https:\/\/doi.org\/10.15586\/aei.v52i3.1024.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"1","key":"1433_CR61","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jaad.2019.09.028","volume":"82","author":"J Raffi","year":"2020","unstructured":"Raffi J, Suresh R, Botto N, Murase JE. The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: a retrospective chart review. J Am Acad Dermatol. 2020;82(1):132\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2019.09.028.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1433_CR62","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ijwd.2019.10.001","volume":"5","author":"J Raffi","year":"2019","unstructured":"Raffi J, Suresh R, Fishman H, Botto N, Murase JE. Investigating the role of allergic contact dermatitis in residual ocular surface disease on dupilumab (ROSDD). Int J Womens Dermatol. 2019;5(5):308\u201313. https:\/\/doi.org\/10.1016\/j.ijwd.2019.10.001.","journal-title":"Int J Womens Dermatol"},{"issue":"3","key":"1433_CR63","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.abd.2022.02.007","volume":"98","author":"NM Suzuki","year":"2023","unstructured":"Suzuki NM, Hafner MFS, Lazzarini R, Duarte IAG, Veasey JV. Patch tests and hand eczema: retrospective study in 173 patients and literature review. An Bras Dermatol. 2023;98(3):339\u201346. https:\/\/doi.org\/10.1016\/j.abd.2022.02.007.","journal-title":"An Bras Dermatol"},{"key":"1433_CR64","unstructured":"Incidence rate of hand eczema in different occupations: a systematic review and meta-analysis\u2014PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/35098319\/. Accessed 11 Feb 2025."},{"key":"1433_CR65","unstructured":"Clinical dermatology review. https:\/\/journals.lww.com\/cddr\/fulltext\/2024\/08040\/patch_test_as_a_helping_hand_in_farmers_with_hand.7.aspx. Accessed 10 Feb 2025."},{"issue":"5","key":"1433_CR66","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/jdv.12735","volume":"29","author":"MB Boonstra","year":"2015","unstructured":"Boonstra MB, Christoffers WA, Coenraads PJ, Schuttelaar MLA. Patch test results of hand eczema patients: relation to clinical types. J Eur Acad Dermatol Venereol. 2015;29(5):940\u20137. https:\/\/doi.org\/10.1111\/jdv.12735.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1433_CR67","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000362901","volume":"229","author":"L Ruppert","year":"2014","unstructured":"Ruppert L, Apfelbacher C, Molin S, et al. Itching in patients with chronic hand eczema: data from the CARPE Registry. Dermatology. 2014;229(2):146\u201353. https:\/\/doi.org\/10.1159\/000362901.","journal-title":"Dermatology"},{"key":"1433_CR68","doi-asserted-by":"publisher","first-page":"adv00626","DOI":"10.2340\/actadv.v101.432","volume":"102","author":"AN Voorberg","year":"2022","unstructured":"Voorberg AN, Loman L, Schuttelaar MLA. Prevalence and severity of hand eczema in the Dutch general population: a cross-sectional, questionnaire study within the lifelines cohort study. Acta Derm Venereol. 2022;102:adv00626. https:\/\/doi.org\/10.2340\/actadv.v101.432.","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"1433_CR69","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/cod.14508","volume":"90","author":"C Lamouroux","year":"2024","unstructured":"Lamouroux C, Bertolotti L, Coste C, et al. Glove-related contact dermatitis: diagnostic value of a repeated application test. Contact Dermatitis. 2024;90(5):528\u201330. https:\/\/doi.org\/10.1111\/cod.14508.","journal-title":"Contact Dermatitis"},{"issue":"2","key":"1433_CR70","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/DER.0000000000000355","volume":"29","author":"TH Zhu","year":"2018","unstructured":"Zhu TH, Suresh R, Farahnik B, et al. Survey of patch test business models in the United States by the American Contact Dermatitis Society. Dermatitis. 2018;29(2):85\u20138. https:\/\/doi.org\/10.1097\/DER.0000000000000355.","journal-title":"Dermatitis"},{"key":"1433_CR71","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/jdv.16062","volume":"34","author":"P Elsner","year":"2020","unstructured":"Elsner P, Agner T. Hand eczema: treatment. J Eur Acad Dermatol Venereol. 2020;34:13\u201321.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1433_CR72","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.2147\/TCRM.S292504","volume":"16","author":"C Dubin","year":"2020","unstructured":"Dubin C, Del Duca E, Guttman-Yassky E. Drugs for the treatment of chronic hand eczema: successes and key challenges. Ther Clin Risk Manag. 2020;16:1319\u201332. https:\/\/doi.org\/10.2147\/TCRM.S292504.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"1433_CR73","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/ijms25010362","volume":"25","author":"V Tancredi","year":"2023","unstructured":"Tancredi V, Buononato D, Caccavale S, et al. New perspectives in the management of chronic hand eczema: lessons from pathogenesis. Int J Mol Sci. 2023;25(1):362. https:\/\/doi.org\/10.3390\/ijms25010362.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1433_CR74","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/bjd.18469","volume":"182","author":"M Worm","year":"2020","unstructured":"Worm M, Bauer A, Elsner P, Mahler V, Molin S, Nielsen TSS. Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double-blind, vehicle-controlled phase IIa study. Br J Dermatol. 2020;182(5):1103\u201310.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1433_CR75","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s40257-024-00890-z","volume":"25","author":"E Weisshaar","year":"2024","unstructured":"Weisshaar E. Chronic hand eczema. Am J Clin Dermatol. 2024;25(6):909\u201326.","journal-title":"Am J Clin Dermatol"},{"key":"1433_CR76","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.anai.2018.07.008","volume":"121","author":"P Elias","year":"2018","unstructured":"Elias P, Sugarman J. Does moisturizing the skin equate with barrier repair therapy? Ann Allergy Asthma Immunol. 2018;121:653-656.e2.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"1433_CR77","doi-asserted-by":"publisher","first-page":"508","DOI":"10.4103\/ijd.ijd_281_21","volume":"66","author":"ZH Ahmed","year":"2021","unstructured":"Ahmed ZH, Agarwal K, Sarkar R. Hand dermatitis: a comprehensive review with special emphasis on COVID-19 pandemic. Indian J Dermatol. 2021;66(5):508. https:\/\/doi.org\/10.4103\/ijd.ijd_281_21.","journal-title":"Indian J Dermatol"},{"issue":"4","key":"1433_CR78","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/cod.14489","volume":"90","author":"YT Y\u00fcksel","year":"2024","unstructured":"Y\u00fcksel YT, Symanzik C, Christensen MO, et al. Prevalence and incidence of hand eczema in healthcare workers: a systematic review and meta-analysis. Contact Dermatitis. 2024;90(4):331\u201342. https:\/\/doi.org\/10.1111\/cod.14489.","journal-title":"Contact Dermatitis"},{"key":"1433_CR79","doi-asserted-by":"publisher","unstructured":"Diepgen TL. Occupational skin diseases. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG.\n2012;10(5):297\u2013313; quiz 314-315. https:\/\/doi.org\/10.1111\/j.1610-0387.2012.07890.x.","DOI":"10.1111\/j.1610-0387.2012.07890.x"},{"key":"1433_CR80","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/cod.14035","volume":"86","author":"J Thyssen","year":"2022","unstructured":"Thyssen J, Schuttelaar M, Alfonso J, et al. Guidelines for diagnosis, prevention, and treatment of hand eczema. Contact Dermatitis. 2022;86:357\u201378.","journal-title":"Contact Dermatitis"},{"key":"1433_CR81","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jdin.2023.11.004","volume":"14","author":"A Egeberg","year":"2024","unstructured":"Egeberg A, Schlapbach C, Haugaard J, et al. Adverse events from topical corticosteroid use in chronic hand eczema\u2014findings from the Danish Skin Cohort. JAAD Int. 2024;14:77\u201383.","journal-title":"JAAD Int."},{"issue":"2","key":"1433_CR82","first-page":"135","volume":"79","author":"JD Ference","year":"2009","unstructured":"Ference JD, Last AR. Choosing topical corticosteroids. Am Fam Physician. 2009;79(2):135\u201340.","journal-title":"Am Fam Physician"},{"issue":"6","key":"1433_CR83","first-page":"337","volume":"103","author":"SK Stacey","year":"2021","unstructured":"Stacey SK, McEleney M. Topical corticosteroids: choice and application. Am Fam Physician. 2021;103(6):337\u201343.","journal-title":"Am Fam Physician"},{"key":"1433_CR84","unstructured":"Ference J, Last A. Choosing topical corticosteroids. 2009."},{"key":"1433_CR85","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/jid.2009.133","volume":"129","author":"M Cork","year":"2009","unstructured":"Cork M, Danby S, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129:1892\u2013908.","journal-title":"J Invest Dermatol"},{"key":"1433_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2023.105341","author":"M Pemberton","year":"2023","unstructured":"Pemberton M, Kimber I. Propylene glycol, skin sensitisation and allergic contact dermatitis: a scientific and regulatory conundrum. Regul Toxicol Pharmacol. 2023. https:\/\/doi.org\/10.1016\/j.yrtph.2023.105341.","journal-title":"Regul Toxicol Pharmacol"},{"key":"1433_CR87","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/ced\/llad161","volume":"48","author":"T Brookes","year":"2023","unstructured":"Brookes T, Barlow R, Mohandas P, et al. Topical steroid withdrawal: an emerging clinical problem. Clin Exp Dermatol. 2023;48:1007\u201311.","journal-title":"Clin Exp Dermatol"},{"key":"1433_CR88","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1111\/jdv.18429","volume":"36","author":"A Wollenberg","year":"2022","unstructured":"Wollenberg A, Kinberger M, Arents B, et al. European guideline (EuroGuiDerm) on atopic eczema\u2014part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol. 2022;36:1904\u201326.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1433_CR89","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40257-015-0130-z","volume":"16","author":"D Antonov","year":"2015","unstructured":"Antonov D, Schliemann S, Elsner P. Hand dermatitis: a review of clinical features, prevention and treatment. Am J Clin Dermatol. 2015;16:257\u201370.","journal-title":"Am J Clin Dermatol"},{"issue":"132","key":"1433_CR90","first-page":"274","volume":"2024","author":"D Chu","year":"2023","unstructured":"Chu D, Schneider L, Asiniwasis R, et al. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology\/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE\u2013 and Institute of Medicine\u2013based recommendations. Ann Allergy Asthma Immunol. 2023;2024(132):274\u2013312.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1433_CR91","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1365-2133.2008.08487.x","volume":"158","author":"T Ruzicka","year":"2008","unstructured":"Ruzicka T, Lynde C, Jemec G, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol. 2008;158:808\u201317.","journal-title":"Br J Dermatol"},{"key":"1433_CR92","unstructured":"Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial\u2014PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/18294310\/. Accessed 25 Feb 2025."},{"issue":"5","key":"1433_CR93","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/12034754231188325","volume":"27","author":"JSS Ho","year":"2023","unstructured":"Ho JSS, Molin S. A review of existing and new treatments for the management of hand eczema. J Cutan Med Surg. 2023;27(5):493\u2013503. https:\/\/doi.org\/10.1177\/12034754231188325.","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"1433_CR94","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jaad.2004.07.043","volume":"52","author":"C Dadlani","year":"2005","unstructured":"Dadlani C, Orlow SJ. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature. J Am Acad Dermatol. 2005;52(2):316\u201340. https:\/\/doi.org\/10.1016\/j.jaad.2004.07.043.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1433_CR95","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1097\/DER.0000000000000793","volume":"32","author":"JS Kahn","year":"2021","unstructured":"Kahn JS, Grossman-Kranseler JS, Zancanaro P, Griffiths D, Dumont N, Rosmarin D. Topical crisaborole in the treatment of atopic hand dermatitis: a retrospective chart review. Dermat Contact Atopic Occup Drug. 2021;32(6):e141\u20133. https:\/\/doi.org\/10.1097\/DER.0000000000000793.","journal-title":"Dermat Contact Atopic Occup Drug"},{"issue":"5","key":"1433_CR96","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/cod.14039","volume":"86","author":"FM Rosenberg","year":"2022","unstructured":"Rosenberg FM, Loman L, Schuttelaar MLA. Baricitinib treatment of severe chronic hand eczema: two case reports. Contact Dermatitis. 2022;86(5):419\u201321. https:\/\/doi.org\/10.1111\/cod.14039.","journal-title":"Contact Dermatitis"},{"issue":"3","key":"1433_CR97","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/ajd.14074","volume":"64","author":"SD Lee","year":"2023","unstructured":"Lee SD, Ahn HJ, Shin MK. Nine cases of chronic hand and foot eczema treated with baricitinib. Australas J Dermatol. 2023;64(3):408\u201312. https:\/\/doi.org\/10.1111\/ajd.14074.","journal-title":"Australas J Dermatol"},{"issue":"6","key":"1433_CR98","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.jaad.2023.12.066","volume":"90","author":"EL Simpson","year":"2024","unstructured":"Simpson EL, Silverberg JI, Worm M, et al. Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol. 2024;90(6):1190\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2023.12.066.","journal-title":"J Am Acad Dermatol"},{"issue":"24","key":"1433_CR99","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","volume":"375","author":"EL Simpson","year":"2016","unstructured":"Simpson EL, Bieber T, Guttman-Yassky E, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375(24):2335\u201348. https:\/\/doi.org\/10.1056\/NEJMoa1610020.","journal-title":"N Engl J Med"},{"issue":"2","key":"1433_CR100","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/cod.14104","volume":"87","author":"AN Voorberg","year":"2022","unstructured":"Voorberg AN, Romeijn GLE, de Bruin-Weller MS, Schuttelaar MLA. The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis\u201452 week results from the Dutch BioDay Registry. Contact Dermatitis. 2022;87(2):185\u201391. https:\/\/doi.org\/10.1111\/cod.14104.","journal-title":"Contact Dermatitis"},{"key":"1433_CR101","unstructured":"LEO Pharma. A phase 3b, interventional, adaptive, clinical trial to evaluate the efficacy and safety of tralokinumab 300 mg every second week monotherapy compared with placebo in subjects with moderate-to-severe atopic hand eczema who are candidates for systemic therapy. clinicaltrials.gov. 2025. https:\/\/clinicaltrials.gov\/study\/NCT05958407. Accessed 31 Mar 2025."},{"key":"1433_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.09.049","author":"R Bissonnette","year":"2024","unstructured":"Bissonnette R, Agner T, Taylor JS, Molin S, Guttman-Yassky E. Hand eczema. Part 2: prevention, management, and treatment. J Am Acad Dermatol. 2024. https:\/\/doi.org\/10.1016\/j.jaad.2024.09.049.","journal-title":"J Am Acad Dermatol"},{"key":"1433_CR103","unstructured":"Schliemann S, Pinter A, Schuttelaar M, et al. Efficacy and safety of delgocitinib cream in adults with moderate-to-severe chronic hand eczema: results of the Phase 3 DELTA 1 trial. In: European academy of dermatology and venereology (EADV) congress. 2023."},{"issue":"4","key":"1433_CR104","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jaad.2019.12.015","volume":"82","author":"H Nakagawa","year":"2020","unstructured":"Nakagawa H, Nemoto O, Igarashi A, Saeki H, Kaino H, Nagata T. Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study. J Am Acad Dermatol. 2020;82(4):823\u201331.","journal-title":"J Am Acad Dermatol"},{"key":"1433_CR105","unstructured":"Association NE. FDA Accepts LEO Pharma\u2019s Filing of Delgocitinib Cream New Drug Application for the Treatment of Chronic Hand Eczema. National Eczema Association. 2024. https:\/\/nationaleczema.org\/blog\/press-release-leo-pharma-delgocitinib-chronic-hand-eczema\/. Accessed 25 Feb 2025."},{"issue":"10451","key":"1433_CR106","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(24)01027-4","volume":"404","author":"R Bissonnette","year":"2024","unstructured":"Bissonnette R, Warren RB, Pinter A, et al. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials. Lancet. 2024;404(10451):461\u201373. https:\/\/doi.org\/10.1016\/S0140-6736(24)01027-4.","journal-title":"Lancet"},{"issue":"4","key":"1433_CR107","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/bjd\/ljad156","volume":"189","author":"AN Voorberg","year":"2023","unstructured":"Voorberg AN, Kamphuis E, Christoffers WA, Schuttelaar MLA. Efficacy and safety of dupilumab in patients with severe chronic hand eczema with inadequate response or intolerance to alitretinoin: a randomized, double-blind, placebo-controlled phase IIb proof-of-concept study. Br J Dermatol. 2023;189(4):400\u20139.","journal-title":"Br J Dermatol"},{"key":"1433_CR108","doi-asserted-by":"publisher","unstructured":"A 24-week trial to compare the efficacy and safety of delgocitinib cream 20 mg\/g twice-daily with alitretinoin capsules once daily in adult participants with severe chronic hand eczema. ISRCTN Registry. https:\/\/doi.org\/10.1186\/ISRCTN44123892.","DOI":"10.1186\/ISRCTN44123892"},{"issue":"1","key":"1433_CR109","doi-asserted-by":"publisher","first-page":"2479126","DOI":"10.1080\/09546634.2025.2479126","volume":"36","author":"A Abdelhalim","year":"2025","unstructured":"Abdelhalim A, Yilmaz O, Elshaikh Berair M, Torres T. Topical delgocitinib for the treatment of chronic hand eczema. J Dermatol Treat. 2025;36(1):2479126. https:\/\/doi.org\/10.1080\/09546634.2025.2479126.","journal-title":"J Dermatol Treat"},{"issue":"9","key":"1433_CR110","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1038\/sj.jid.5700841","volume":"127","author":"B Meding","year":"2007","unstructured":"Meding B, Wrangsj\u00f6 K, J\u00e4rvholm B. Hand eczema extent and morphology\u2014association and influence on long-term prognosis. J Invest Dermatol. 2007;127(9):2147\u201351. https:\/\/doi.org\/10.1038\/sj.jid.5700841.","journal-title":"J Invest Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01433-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01433-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01433-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T09:59:34Z","timestamp":1748685574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01433-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,18]]},"references-count":110,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1433"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01433-y","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,18]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Raj Chovatiya has served as an advisor, consultant, speaker, and\/or investigator for AbbVie, Acelyrin, Alumis, Amgen, AnaptysBio, Apogee Therapeutics, Arcutis Biotherapeutics Inc., Argenx, Astria Therapeutics Inc., Avalere Health, Beiersdorf, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Celldex CLn Skin Care, Dermavant, Eli Lilly and Company, EMD Serono, Formation Bio, Galderma, Genentech, GSK, Incyte, Johnson & Johnson, Kenvue, LEO Pharma, L\u2019Or\u00e9al, Nektar Therapeutics, Novartis, Opsidio, Pfizer Inc., RAPT, Regeneron, Sanofi, Sitryx, Takeda, TRex Bio, UCB, and Zai Lab. Raj Chovatiya is on the editorial board of Dermatology and Therapy. Raj Chovatiya was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Sophia Mense and Sawyeh Maher have no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}